{
  "id": 20519116,
  "title": "Alcohol Suppresses Some T Cells, Boosts Others, Blunting Anti-PD-1 Response in Mice",
  "url": "https://urgent.news/2026/11/17/alcohol-suppresses-some-t-cells-boosts-others-blunting-anti-pd-1",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-17T23:36:40.000Z",
  "source": {
    "name": "GEN Biotechnology",
    "slug": "gen-biotechnology",
    "url": "https://www.genengnews.com/topics/cancer/alcohol-suppresses-some-t-cells-boosts-others-blunting-anti-pd-1-response-in-mice/"
  },
  "original_language": "en",
  "account": "A recent study conducted by researchers at the University of North Carolina at Chapel Hill has found that regular alcohol consumption may reduce the effectiveness of cancer immunotherapy, specifically anti-PD-1 antibodies. Published in Science Signaling, the research indicates that alcohol use may weaken some T cells while enhancing others, negatively impacting anti-tumor immunity. The study involved administering moderate-to-heavy ethanol to mouse models of lung and bladder cancer, combined with anti-PD-1 treatment. The findings showed that alcohol reduced the efficacy of immunotherapy by about 50% and increased tumor recurrence. In mice with MB49 bladder tumors, alcohol decreased the number of tumor-infiltrating T cells, shifted CD4+ T cells towards a T helper 17 profile, reduced tissue-resident memory T cells, and increased the proportion of T cells expressing TIGIT, an alternative immune checkpoint receptor. The researchers also analyzed a cohort of patients with various cancers who had received immune checkpoint inhibitors. Patients who reported drinking eight or more drinks a week had poorer survival after starting treatment, particularly in lung cancer patients. The study suggests that targeting specific changes caused by alcohol consumption, such as TIGIT and SREBP-mediated lipid signaling, could help restore the effectiveness of anti-PD-1 treatment. The authors recommend incorporating patients' alcohol use into cancer databases to better understand its impact on various therapies, such as CAR T cell therapy, chemotherapy, and radiation across multiple cancers.",
  "summary": "In mice, alcohol cut the efficacy of anti-PD-1 immunotherapy by roughly 50%, suppressing tumor-infiltrating and memory T cells while boosting TIGIT-carrying ones. Blocking TIGIT restored the response. The post Alcohol Suppresses Some T Cells, Boosts Others, Blunting Anti-PD-1 Response in Mice appeared first on GEN - Genetic Engineering and Biotechnology News .",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}